Select a Sector or Industry
Revenue Growth Rankings for Biotechnology Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Revenue Growth
|
Pro Rating
|
|---|---|---|---|---|
| 1 | BDSI | BioDelivery Sciences International | 13000% | Go Pro |
| 2 | CRIS | Curis | 7658% | Go Pro |
| 3 | GEVA | Synageva BioPharma | 3766% | Go Pro |
| 4 | ACHN | Achillion Pharmaceuticals | 3729% | Go Pro |
| 5 | PACB | Pacific Biosciences of California | 3618% | Go Pro |
| 6 | OSIR | Osiris Therapeutics | 2973% | Go Pro |
| 7 | XNPT | XenoPort | 2639% | Go Pro |
| 8 | CADX | Cadence Pharmaceuticals | 2187% | Go Pro |
| 9 | THRX | Theravance | 1908% | Go Pro |
| 10 | AGEN | Agenus | 1891% | Go Pro |
| 11 | VICL | Vical | 1666% | Go Pro |
| 12 | IDIX | Idenix Pharmaceuticals | 790.9% | Go Pro |
| 13 | VRTX | Vertex Pharmaceuticals | 495.6% | Go Pro |
| 14 | NVAX | Novavax | 456.6% | Go Pro |
| 15 | SGEN | Seattle Genetics | 296.4% | Go Pro |
| 16 | AFFY | Affymax | 278.9% | Go Pro |
| 17 | DNDN | Dendreon Corporation | 203.7% | Go Pro |
| 18 | ZIOP | Ziopharm Oncology | 198.5% | Go Pro |
| 19 | SVNT | Savient Pharmaceuticals | 174.0% | Go Pro |
| 20 | EBS | Emergent BioSolutions | 171.5% | Go Pro |
| 21 | QCOR | Questcor Pharmaceuticals | 160.5% | Go Pro |
| 22 | MDVN | Medivation | 150.4% | Go Pro |
| 23 | CVM | Cel-Sci Corporation | 143.2% | Go Pro |
| 24 | CYTK | Cytokinetics | 138.5% | Go Pro |
| 25 | SVA | Sinovac Biotech | 131.3% | Go Pro |
| 26 | BCRX | BioCryst Pharmaceuticals | 124.9% | Go Pro |
| 27 | RGEN | Repligen Corporation | 117.1% | Go Pro |
| 28 | JAZZ | Jazz Pharmaceuticals | 113.1% | Go Pro |
| 29 | REGN | Regeneron Pharmaceuticals | 106.6% | Go Pro |
| 30 | SNTS | Santarus | 101.1% | Go Pro |
| 31 | BPAX | Biosante Pharmaceuticals | 100.0% | Go Pro |
| 32 | ZLCS | Zalicus | 82.53% | Go Pro |
| 33 | HGSI | Human Genome Sciences | 77.35% | Go Pro |
| 34 | NKTR | Nektar Therapeutics | 58.85% | Go Pro |
| 35 | SGMO | Sangamo BioSciences | 47.36% | Go Pro |
| 36 | ALXN | Alexion Pharmaceuticals | 47.32% | Go Pro |
| 37 | SSRX | 3SBio | 44.97% | Go Pro |
| 38 | ARIA | ARIAD Pharmaceuticals | 44.64% | Go Pro |
| 39 | HEB | Hemispherx Biopharma | 40.74% | Go Pro |
| 40 | ITMN | InterMune | 40.68% | Go Pro |
| 41 | DYAX | Dyax | 39.87% | Go Pro |
| 42 | BSTC | Biospecifics Technologies | 39.30% | Go Pro |
| 43 | SPPI | Spectrum Pharmaceuticals | 37.30% | Go Pro |
| 44 | CERS | Cerus Corporation | 32.68% | Go Pro |
| 45 | FOLD | Amicus Therapeutics | 30.31% | Go Pro |
| 46 | BONE | Bacterin International | 29.48% | Go Pro |
| 47 | AEZS | AEterna Zentaris | 26.37% | Go Pro |
| 48 | CBP | China Botanic Pharmaceutical | 24.38% | Go Pro |
| 49 | ANIK | Anika Therapeutics | 22.35% | Go Pro |
| 50 | IG | IGI Laboratories | 21.45% | Go Pro |